PCK2 and type 2 diabetes mellitus: During insulin resistance in type 2 diabetes, the inhibitory effect of insulin on hepatic gluconeogenesis is reduced, and the expressions of gluconeogenesis proteins PEPCK and G-6-Pase were increased.